COMMUNIQUÉS West-GlobeNewswire

Bone Therapeutics appoints Jean-Luc Vandebroek as Chief Financial Officer

31/08/2017 - 07:00

Regulated information Bone Therapeutics appoints Jean-Luc Vandebroek as Chief Financial Officer Wim Goemaere to remain as a Non-Executive Director Gosselies, Belgium, 31 August 2017, 7am CEST - BONE THERAPEUTICS ( [...]

Bone Therapeutics nomme Jean-Luc Vandebroek au poste de Directeur financier

31/08/2017 - 07:00

Information réglementée Bone Therapeutics nomme Jean-Luc Vandebroek au poste de Directeur financier Wim Goemaere devient Administrateur non exécutif Gosselies, Belgique, le 31 août 2017, 7h00 CET - BONE THERAPEUTICS ( [...]

Merus participera à deux conférences Investisseurs en septembre 2017

30/08/2017 - 20:23

UTRECHT, Pays-Bas, le 30 août 2017 (GLOBE NEWSWIRE) - Merus N.V. (Nasdaq : MRUS), une entreprise d'immuno-oncologie de stade clinique qui développe des traitements innovants à base d'anticorps bispécifiques (Biclonics [...]

Novartis receives first ever FDA approval for a CAR-T cell therapy, Kymriah(TM) (CTL019), for children and young adults with B-cell ALL that is refractory or has relapsed at least twice

30/08/2017 - 17:04

Media Release (PDF) This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]

ObsEva SA to Attend Baird Global Healthcare Conference and Rodman & Renshaw Annual Global Investment Conference in NYC

30/08/2017 - 13:00

Geneva, Switzerland and Boston, MA - 30 August, 2017 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]

Merus to Participate in Two Investor Conferences in September 2017

30/08/2017 - 13:00

UTRECHT, The Netherlands, Aug. 30, 2017 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that [...]

Amer Sports updates its 2020 growth target, prioritizing Sustainable Profitable Growth

30/08/2017 - 12:00

Amer Sports Corporation STOCK EXCHANGE RELEASE August 30, 2017 at 1:00 p.m. Amer Sports updates its 2020 growth target, prioritizing Sustainable Profitable Growth Amer Sports Corporation has updated the company's 2020 [...]

Optalysys and The Earlham Institute Demonstrate Results of Breakthrough Optical Processing for Sequence Alignment

30/08/2017 - 09:00

Prototype Technology to Advance and Democratize High-Performance Genomic Research NORWICH, U.K., Aug. 30, 2017 (GLOBE NEWSWIRE) -- Optalysys Ltd . (@Optalysys), a start-up pioneering the development of light-speed [...]

Nicox réaffirme son éligibilité au PEA-PME

30/08/2017 - 07:30

Communiqué de presse Nicox réaffirme son éligibilité au PEA-PME 30 août 2017 - diffusion à 7h30 Sophia Antipolis, France Nicox S.A. (Euronext Paris : FR0013018124, COX, éligible PEA-PME), société internationale [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

30/08/2017 - 07:02

REGULATED INFORMATION GHENT, Belgium, 30 August 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

30/08/2017 - 07:00

REGULATED INFORMATION GHENT, Belgium, 30 August 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

Abiomed annonce la démission de son Directeur financier et se réjouit du retour de son prédécesseur en qualité de consultant

30/08/2017 - 00:38

DANVERS, Massachusetts, le 28 août 2017 (GLOBE NEWSWIRE) - Abiomed, Inc. (NASDAQ : ABMD), un des plus grands fournisseurs de technologies innovantes d'assistance et de soin cardiaque, a annoncé aujourd'hui la démission [...]

Les données intermédiaires sur MobiusHD présentées à la Société européenne de cardiologie s'avèrent prometteuses dans le traitement de l'hypertension artérielle résistante

29/08/2017 - 20:53

MOUNTAIN VIEW, Californie, le 29 août 2017 (GLOBE NEWSWIRE) - Vascular Dynamics, Inc., (VDI), société privée de dispositifs médicaux qui développe de nouvelles solutions pour le traitement de l'hypertension artérielle, [...]

Solon Eiendom ASA - Primary insider notification

29/08/2017 - 17:53

SOLON EIENDOM ASA STOCK EXCHANGE ANNOUNCEMENT Solon Eiendom ASA - Primary insider notification (Oslo, Norway, 29 August 2017) Per Knut Asphaug Bernhardt, personal assistant to the chairman of the board of Solon Eiendom [...]

Solon Eiendom ASA - Primary insider notification

29/08/2017 - 17:52

SOLON EIENDOM ASA STOCK EXCHANGE ANNOUNCEMENT Solon Eiendom ASA - Primary insider notification (Oslo, Norway, 29 August 2017) Solon Eiendom ASA Financial Controller Arne Post has today bought 4,000 shares in Solon [...]

Solon Eiendom ASA - Primary insider notification

29/08/2017 - 17:51

SOLON EIENDOM ASA STOCK EXCHANGE ANNOUNCEMENT Solon Eiendom ASA - Primary insider notification (Oslo, Norway, 29 August 2017) Solon Eiendom ASA CEO Andreas Martinussen (through his wholly owned company John Galt Invest [...]

Solon Eiendom ASA - Primary insider notification

29/08/2017 - 17:50

SOLON EIENDOM ASA STOCK EXCHANGE ANNOUNCEMENT Solon Eiendom ASA - Primary insider notification (Oslo, Norway, 29 August 2017) Solon Eiendom ASA Chairman of the Board Simen Thorsen (through his wholly owned company [...]

RAMSAY GENERALE DE SANTE : résultats annuels au 30 juin 2017

29/08/2017 - 17:35

COMMUNIQUE DE PRESSE Paris, le 29 Août 2017 Résultats annuels à fin juin 2017 Des résultats résilients malgré une nouvelle année de baisse tarifaire Chiffre d'affaires annuel en hausse de 0.3% à 2 234,4 millions d'euros [...]

RAMSAY GENERALE DE SANTE : annual Results at the end of June 2017

29/08/2017 - 17:35

PRESS RELEASE Paris, 29 August 2017 Annual results at the end of June 2017 Strong performance despite a year of further price cuts Annual turnover up 0.3% to EUR 2,234.4 million (down 1.4% on a like-for-like basis) with [...]